Please login to the form below
vildagliptin
This page shows the latest vildagliptin news and features for those working in and with pharma, biotech and healthcare.
Novartis to make 15 drugs available at $1 a month
Among the drugs to be made available under the scheme are high blood pressure medicine valsartan, tamoxifen for breast cancer and vildagliptin for diabetes.
Latest news
-
AZ sues to block generic saxagliptin from Mylan
world market for DPP4 inhibitors, a class which also includes Merck &Co's market-leading Januvia (sitagliptin), Novartis' Galvus (vildagliptin) and Boehringer Ingelheim/Lilly's Trajenta (linagliptin).
-
Pfizer still number one - just
Meanwhile, Novartis kept the pressure on with solid performances for its own new entrants, including Gilenya (fingolimod) for multiple sclerosis, cancer drugs Afinitor/Votubia (everolimus) and Tasigna (nilotinib) and Galvus (vildagliptin)
-
NICE turns down Afinitor for breast cancer
for leukaemia, Galvus (vildagliptin) for diabetes and blood cancer therapy Jakavi (ruxolitinib).
-
Novartis lifts 2013 guidance on delay to Diovan generics
Gilenya (fingolimod), Afinitor (everolimus) for breast cancer, leukaemia therapy Tasigna (nilotinib) and Galvus (vildagliptin) for diabetes just about offsetting revenue losses to generic competition of some $800m in the quarter.
-
Setback for AZ and BMS as Onglyza flunks cardiovascular trial
vildagliptin). The trial was set up in the wake of new US FDA guidelines in 2009 which required pharma companies to perform cardiovascular outcome studies on new diabetes drugs.
More from news
Approximately 1 fully matching, plus 32 partially matching documents found.
Latest appointments
-
bmore creative hires Kush Rach as new business director
He was a key account manager at the pharma company, where he worked in the diabetes therapeutic area, and was involved in the UK launch of Galvus (vildagliptin) for type 2
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
- Business Unit Head, Medical Communications, London
-
Excellent package
- Home based, Chief Medical Writer, Medical Communications
-
Excellent package
- Home based, Principal Medical Writer, Medical Communications
-
Excellent package
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
- Home based, Editorial Team Leader, Medical Communications
-
Excellent package
-
Client Services Director - Med Comms
-
Great salary and bebefits
- Account Director, Consumer Healthcare PR, Global PR agency
-
£50, 000 – £58, 000
-
Account Manager
-
£40, 000 - £45, 000 benefits
- Senior Project Manager - Medical Writing
-
Great salary and bebefits
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
-
Senior Account Manager
-
Competitive salary commensurate with experience
Subscribe to our email news alerts
- Communiqué Awards 2018: Photo Gallery - Communiqué Awards 2016
- GSK sells eczema and psoriasis drug to Dermavant for £250m
- NHS England says yes to Roche's Hemlibra
- Moving annual total (MAT)
- Roche keeps Venclexta train rolling with new leukaemia filing
- Communiqué Awards 2018: Winners in pictures - Communiqué Awards 2016
- Pfizer enters late-stage haemophilia B gene therapy trial
- Porterhouse Medical strengthens the team with three new members.
- Developing advocacy in the pharmaceutical industry.
- Roche’s Tamiflu successor hits the mark in complicated flu
- Novartis launch NET cancer community app
- J&J’s Invokana aces diabetic kidney disease trial, setting up filings
Latest intelligence
- Developing advocacy in the pharmaceutical industry.
- The importance of advocacy programmes...
- GDPR and events. What does the pharma industry need to know?
- Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
- Digital trends in B2B sales - how far behind is Pharma?
- The modern approach to B2B sales is data-driven, and enabled by digital tools....
Quick links
Infographics
